• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Recognized Consensus Standards

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

New Search Back To Search Results
Part B: Supplementary Information Sheet (SIS)
FR Recognition List Number 038 Date of Entry 01/27/2015 
FR Recognition Number 11-283
Standard
ASTM F2943-14 (Reapproved 2019)
Standard Guide for Presentation of End User Labeling Information for Orthopedic Implants Used in Joint Arthroplasty
Scope/Abstract
1.1 The goal of this guide is to recommend a universal label format (across manufacturers and various implants) of content and relative location of information necessary for final implant selection within an implant's overall package labeling.

1.2 This guide recommends package labeling for musculoskeletal based implants individually processed and packaged with the intent of being opened at the point of use, typically in the operating room.

1.3 This guide identifies the necessary, "high priority" label content and recommendations for the layout and location of information for accurate implant identification by the end users in the operating room environment.

1.4 This goal is achieved by creating a partitioned, secondary area of an implant's package label or a separate label to present this information uniformly.

1.5 The authors of this guide identified the competing needs of regulatory requirements, manufacturing/distribution, and implant identification. It is recognized through our task group's efforts that, if a manufacturer elects to implement these recommendations, balancing these competing needs may necessitate changing a manufacturer's internal processes, relabeling their entire inventory (either at a single point in time or over a defined time period), or accepting duplicate information on an implant's package label. No additional compromises that would allow the primary goal of uniform implant label design across manufacturers were identified.

1.6 It is not the intent of this guide to limit or dictate overall package labeling content.

1.7 It is not the intent of this guide to supplant existing regulatory requirements (only to augment or complement existing regulatory label requirements).

1.8 The use or application of multiple languages is not prevented by this guide; however, use of more than one language is discouraged on the implant selection sublabel (ISSL) defined in this guide. The language of choice is left to the manufacturer and should be dictated by the end user and regulatory requirements in the jurisdictions where the device is marketed. International symbols should also be considered to avoid the need for multiple ISSLs where possible.

1.9 Use and implementation of this guide is optional and at the sole discretion of the implant's manufacturer. It shall be implemented with the following considerations:

1.9.1 The content and layout of any orthopedic implant label should be influenced by risk management activities and all label formats should be validated.

1.9.2 If internal risk management activities recommend deviation from this guide, the manufacturer is discouraged from implementing a hybrid label that partially applies the principles and recommendations in this guide.
Extent of Recognition
Complete standard
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.
FDA Technical Contact
 John Goode
  FDA/OC/CDRH/OPEQ/OHTVI/DHTVIA/
  301-796-6407
  john.goode@fda.hhs.gov
Standards Development Organization
ASTM ASTM International http://www.astm.org/
FDA Specialty Task Group (STG)
Orthopedic
-
-